{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T23:02:40Z","timestamp":1769554960378,"version":"3.49.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T00:00:00Z","timestamp":1573171200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T00:00:00Z","timestamp":1573171200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Health Research Board Ireland","award":["HRA-PHR-2014- 508"],"award-info":[{"award-number":["HRA-PHR-2014- 508"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Health Econ"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s10198-019-01125-3","type":"journal-article","created":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T15:20:27Z","timestamp":1573226427000},"page":"261-274","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The impact of prescription drug co-payments for publicly insured families"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1525-0841","authenticated-orcid":false,"given":"Gretta","family":"Mohan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4597-180X","authenticated-orcid":false,"given":"Anne","family":"Nolan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,8]]},"reference":[{"issue":"1","key":"1125_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10198-011-0353-8","volume":"13","author":"M Drummond","year":"2012","unstructured":"Drummond, M., Towse, A.: Is it time to reconsider the role of patient co-payments for pharmaceuticals in Europe? Eur. J. Health Econ. 13(1), 1\u20135 (2012)","journal-title":"Eur. J. Health Econ."},{"issue":"1","key":"1125_CR2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2190\/4M3E-L0YF-W1TD-EKG0","volume":"34","author":"J Lexchin","year":"2004","unstructured":"Lexchin, J., Grootendorst, P.: Effects of prescription drug user fees on drug and health services use and on health status in vulnerable populations: a systematic review of the evidence. Int. J. Health Serv. 34(1), 101\u2013122 (2004)","journal-title":"Int. J. Health Serv."},{"key":"1125_CR3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1475-9276-7-12","volume":"7","author":"MC Gemmill","year":"2008","unstructured":"Gemmill, M.C., Thomson, S., Mossialos, E.: What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries. Int. J. Equity Health 7, 13\u201316 (2008)","journal-title":"Int. J. Equity Health"},{"issue":"1","key":"1125_CR4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1001\/jama.298.1.61","volume":"298","author":"DP Goldman","year":"2007","unstructured":"Goldman, D.P., Joyce, G.F., Zheng, Y.: Prescription drug cost sharing: associations with medication and medical utilization and spending and health. J. Am. Med. Assoc. 298(1), 61\u201369 (2007)","journal-title":"J. Am. Med. Assoc."},{"issue":"4","key":"1125_CR5","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1377\/hlthaff.28.4.w607","volume":"28","author":"TM Selden","year":"2009","unstructured":"Selden, T.M., Kenney, G.M., Pantell, M.S., Ruhter, J.: Cost sharing in medicaid and CHIP: how does it affect out-of-pocket spending? Health Aff. 28(4), 607\u2013619 (2009)","journal-title":"Health Aff."},{"key":"1125_CR6","doi-asserted-by":"crossref","unstructured":"Williams, A.J., Henley W., Frank, J.: Impact of abolishing prescription fees in Scotland on hospital admissions and prescribed medicines: an interrupted time series evaluation, 1\u201310 (2018)","DOI":"10.1136\/bmjopen-2017-021318"},{"issue":"5","key":"1125_CR7","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1524-4733.2010.00717.x","volume":"13","author":"D Cohen","year":"2010","unstructured":"Cohen, D., Alam, M.F., Dunstan, F.D.J., Myles, S., Hughes, D.A., Routledge, P.A.: Abolition of prescription copayments in Wales: an observational study on dispensing rates. Value Health 13(5), 675\u2013680 (2010)","journal-title":"Value Health"},{"key":"1125_CR8","volume-title":"Health System Responses to Financial Pressures in Ireland: Policy Options in an International Context","author":"S Thomson","year":"2014","unstructured":"Thomson, S., Jowett, M., Mladovsky, P., Evetovits, T., Figueras, J., Nolan, A.: Health System Responses to Financial Pressures in Ireland: Policy Options in an International Context. European Observatory on Health Systems and Policy, World Health Organisation, Geneva (2014)"},{"key":"1125_CR9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1371\/journal.pone.0064914","volume":"8","author":"SJ Sinnott","year":"2013","unstructured":"Sinnott, S.J., Buckley, C., O\u2019Riordan, D., Bradley, C., Whelton, H.: The effect of copayments for prescriptions on adherence to prescription medicines in publicly insured populations; a systematic review and meta-analysis. PLoS One. 8, 5 (2013)","journal-title":"PLoS One."},{"issue":"1","key":"1125_CR10","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1257\/aer.100.1.193","volume":"100","author":"A Chandra","year":"2011","unstructured":"Chandra, A., Gruber, J., McKnight, R.: Patient cost-sharing and hospitalization offsets in the elderly. Am. Econ. Rev. 100(1), 193\u2013213 (2011)","journal-title":"Am. Econ. Rev."},{"issue":"2","key":"1125_CR11","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2202\/1558-9544.1084","volume":"10","author":"M Gaynor","year":"2007","unstructured":"Gaynor, M., Li, J., Vogt, W.: Substitution, spending offsets, and prescription drug benefit design. Forum Health Econ. Policy. 10(2), 4 (2007)","journal-title":"Forum Health Econ. Policy."},{"issue":"4","key":"1125_CR12","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jama.285.4.421","volume":"285","author":"R Tamblyn","year":"2001","unstructured":"Tamblyn, R., Hanley, J.A., Abrahamowicz, M., Scott, S., Mayo, N., Hurley, J.: Prescription drug cost-sharing among poor and elderly persons. J. Am. Med. Assoc. 285(4), 421\u2013429 (2001)","journal-title":"J. Am. Med. Assoc."},{"key":"1125_CR13","volume-title":"Health in Ireland. Key Trends 2018","author":"Department of Health","year":"2018","unstructured":"Department of Health: Health in Ireland. Key Trends 2018. Government of Ireland, Dublin (2018)"},{"issue":"3","key":"1125_CR14","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s11845-015-1360-z","volume":"185","author":"C Brown","year":"2016","unstructured":"Brown, C., Barron, T.I., Bennett, K., MacDonald, D., Dwane, F., Sharp, L.: Generalisability of pharmacoepidemiological studies using restricted prescription data. Ir. J. Med. Sci. 185(3), 723\u2013727 (2016)","journal-title":"Ir. J. Med. Sci."},{"issue":"1","key":"1125_CR15","first-page":"93","volume":"49","author":"S Connolly","year":"2018","unstructured":"Connolly, S., Nolan, A., Walsh, B., Wren, M.A.: Universal GP care in Ireland: potential cost implications. Econ. Soc. Rev. (Irel). 49(1), 93\u2013109 (2018)","journal-title":"Econ. Soc. Rev. (Irel)."},{"issue":"3","key":"1125_CR16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1586\/erp.10.23","volume":"10","author":"M Barry","year":"2010","unstructured":"Barry, M., Usher, C., Tilson, L.: Public drug expenditure in the Republic of Ireland. Expert Rev. Pharmacoecon. Outcomes Res. 10(3), 239\u2013245 (2010)","journal-title":"Expert Rev. Pharmacoecon. Outcomes Res."},{"key":"1125_CR17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0149-2918(96)80035-X","volume":"18","author":"S Hong","year":"1996","unstructured":"Hong, S., Shepherd, M.D.: Outpatient prescription drug use by children enrolled in five drug benefit plans. Clin. Ther. 18, 3 (1996)","journal-title":"Clin. Ther."},{"key":"1125_CR18","doi-asserted-by":"crossref","first-page":"a2245","DOI":"10.1136\/bmj.a2245","volume":"337","author":"MCJM Sturkenboom","year":"2008","unstructured":"Sturkenboom, M.C.J.M., Verhamme, K.M.C., Nicolosi, A., et al.: Drug use in children: cohort study in three European countries. Br. Med. J. 337, a2245 (2008)","journal-title":"Br. Med. J."},{"issue":"2","key":"1125_CR19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s002280100279","volume":"57","author":"H Madsen","year":"2001","unstructured":"Madsen, H., Andersen, M., Hallas, J.: Drug prescribing among Danish children: a population-based study. Eur. J. Clin. Pharmacol. 57(2), 159\u2013165 (2001)","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"5","key":"1125_CR20","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1046\/j.1365-2125.2000.00275.x","volume":"50","author":"E Schirm","year":"2000","unstructured":"Schirm, E., Van den Berg, P., Gebben, H., Sauer, P., De Jong-van den Berg, L.: Drug use of children in the community assessed through pharmacy dispensing data. Br. J. Clin. Pharmacol. 50(5), 473\u2013478 (2000)","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"3","key":"1125_CR21","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1365-2125.2007.03029.x","volume":"65","author":"E Fern\u00e1ndez-Liz","year":"2008","unstructured":"Fern\u00e1ndez-Liz, E., Modamio, P., Catal\u00e1n, A., Lastra, C.F., Rodr\u00edguez, T., Mari\u00f1o, E.L.: Identifying how age and gender influence prescription drug use in a primary health care environment in Catalonia, Spain. Br. J. Clin. Pharmacol. 65(3), 407\u2013417 (2008)","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"6","key":"1125_CR22","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1093\/fampra\/cmv091","volume":"32","author":"E Barry","year":"2015","unstructured":"Barry, E., Smith, S.M.: Potentially inappropriate prescribing in children. Fam. Pract. 32(6), 603\u2013604 (2015)","journal-title":"Fam. Pract."},{"issue":"23","key":"1125_CR23","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1001\/jama.287.23.3133","volume":"287","author":"ME Pichichero","year":"2002","unstructured":"Pichichero, M.E.: Dynamics of antibiotic prescribing for children. J. Am. Med. Assoc. 287(23), 3133\u20133135 (2002)","journal-title":"J. Am. Med. Assoc."},{"key":"1125_CR24","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1002\/pds.2346","volume":"21","author":"C Keogh","year":"2012","unstructured":"Keogh, C., Motterlini, N., Reulbach, U., Bennett, K., Fahey, T.: Antibiotic prescribing trends in a paediatric sub-population in Ireland. Pharmacoepidemiol. Drug Saf. 21, 945\u2013952 (2012)","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"5","key":"1125_CR25","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1503\/jpn.120140","volume":"37","author":"PR Albert","year":"2012","unstructured":"Albert, P.R.: Drugs for kids: good or bad? J. Psychiatry Neurosci. 37(5), 293\u2013295 (2012)","journal-title":"J. Psychiatry Neurosci."},{"key":"1125_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12887-015-0435-3","volume":"15","author":"F Boland","year":"2015","unstructured":"Boland, F., Galvin, R., Reulbach, U., et al.: Psychostimulant prescribing trends in a paediatric population in Ireland: a national cohort study. BMC Pediatr. 15, 1 (2015)","journal-title":"BMC Pediatr."},{"key":"1125_CR27","first-page":"5","volume":"2015","author":"VL Luiza","year":"2015","unstructured":"Luiza, V.L., Chaves, L.A., Silva, R.M., et al.: Pharmaceutical policies: Effects of cap and co-payment on rational use of medicines. Cochrane Database Syst. Rev. 2015, 5 (2015)","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"1125_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-8510(02)00011-8","volume":"62","author":"H Reuveni","year":"2002","unstructured":"Reuveni, H., Sheizaf, B., Elhayany, A., et al.: The effect of drug co-payment policy on the purchase of prescription drugs for children with infections in the community. Health Policy (New York). 62(1), 1\u201313 (2002)","journal-title":"Health Policy (New York)."},{"issue":"12","key":"1125_CR29","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1001\/jama.2012.340","volume":"307","author":"P Karaca-Mandic","year":"2012","unstructured":"Karaca-Mandic, P., Jena, A.B., Joyce, G.F., Goldman, D.P.: Out-of-pocket medication costs and use of medications and health care services among children with asthma. J. Am. Med. Assoc. 307(12), 1284\u20131291 (2012)","journal-title":"J. Am. Med. Assoc."},{"issue":"7","key":"1125_CR30","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1001\/jamapediatrics.2014.79","volume":"168","author":"V Fung","year":"2014","unstructured":"Fung, V., Graetz, I., Galbraith, A., et al.: Financial barriers to care among low-income children with asthma: health care reform implications. JAMA Pediatr. 168(7), 649\u2013656 (2014)","journal-title":"JAMA Pediatr."},{"issue":"2","key":"1125_CR31","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1001\/archpediatrics.2007.21","volume":"162","author":"WJ Ungar","year":"2008","unstructured":"Ungar, W.J., Kozyrskyj, A., Paterson, M., Ahmad, F.: Effect of cost-sharing on use of asthma medication in children. Arch. Pediatr. Adolesc. Med. 162(2), 104\u2013110 (2008)","journal-title":"Arch. Pediatr. Adolesc. Med."},{"issue":"1","key":"1125_CR32","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/1475-6773.12615","volume":"53","author":"AA Galbraith","year":"2018","unstructured":"Galbraith, A.A., Fung, V., Li, L., et al.: Impact of copayment changes on children\u2019s albuterol inhaler use and costs after the clean air act chlorofluorocarbon ban. Health Serv. Res. 53(1), 156\u2013174 (2018)","journal-title":"Health Serv. Res."},{"issue":"4","key":"1125_CR33","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1001\/archpsyc.62.4.435","volume":"62","author":"HA Huskamp","year":"2005","unstructured":"Huskamp, H.A., Deverka, P.A., Epstein, A.M., et al.: Impact of 3-tier formularies on drug treatment of attention-deficit\/hyperactivity disorder in children. Arch. Gen. Psychiatry. 62(4), 435\u2013441 (2005)","journal-title":"Arch. Gen. Psychiatry."},{"issue":"7","key":"1125_CR34","first-page":"897","volume":"165","author":"AL Kozyrskyj","year":"2001","unstructured":"Kozyrskyj, A.L., Mustard, C.A., Cheang, M.S., Simons, F.E.R.: Income-based drug benefit policy: impact on receipt of inhaled corticosteroid prescriptions by Manitoba children with asthma. Can. Med. Assoc. J. 165(7), 897\u2013902 (2001)","journal-title":"Can. Med. Assoc. J."},{"issue":"4","key":"1125_CR35","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1111\/j.1475-6773.2012.01384.x","volume":"47","author":"B Sen","year":"2012","unstructured":"Sen, B., Blackburn, J., Morrisey, M.A., et al.: Did copayment changes reduce health service utilization among CHIP enrollees? Evidence from Alabama. Health Serv. Res. 47(4), 1603\u20131620 (2012)","journal-title":"Health Serv. Res."},{"issue":"2","key":"1125_CR36","first-page":"E1","volume":"4","author":"B Sen","year":"2014","unstructured":"Sen, B., Justin Blackburn, J., Morrisey, M., et al.: Can increases in CHIP copayments reduce program expenditures on prescription drugs? Med. Med. Res. Rev. 4(2), E1\u2013E18 (2014)","journal-title":"Med. Med. Res. Rev."},{"key":"1125_CR37","volume-title":"Growing up in Ireland: Design, Instrumentation and Procedures for the Child Cohort (at 9 Years)","author":"A Murray","year":"2014","unstructured":"Murray, A., McCrory, C., Thornton, M., et al.: Growing up in Ireland: Design, Instrumentation and Procedures for the Child Cohort (at 9 Years). Department of Health and Children, Dublin (2014)"},{"key":"1125_CR38","volume-title":"Growing up in Ireland: Design, Instrumentation and Procedures for the Infant Cohort at Wave One (9 Months)","author":"M Thornton","year":"2013","unstructured":"Thornton, M., Williams, J., McCrory, C., Murray, A., Quail, A.: Growing up in Ireland: Design, Instrumentation and Procedures for the Infant Cohort at Wave One (9 Months). Department of Children and Youth Affairs, Dublin (2013)"},{"key":"1125_CR39","volume-title":"Growing up in Ireland: Design, Instrumentation and Procedures for the Infant Cohort at Wave Two (3 Years)","author":"C McCrory","year":"2013","unstructured":"McCrory, C., Williams, J., Murray, A., Quail, A., Thornton, M.: Growing up in Ireland: Design, Instrumentation and Procedures for the Infant Cohort at Wave Two (3 Years). Department of Children and Youth Affairs, Dublin (2013)"},{"key":"1125_CR40","volume-title":"Growing up in Ireland: Design, Instrumentation and Procedures for the Child Cohort at Wave Two (13 Years)","author":"M Thornton","year":"2016","unstructured":"Thornton, M., Williams, J., McCrory, C., Murray, A., Quail, A.: Growing up in Ireland: Design, Instrumentation and Procedures for the Child Cohort at Wave Two (13 Years). Department of Children and Youth Affairs, Dublin (2016)"},{"key":"1125_CR41","volume-title":"Principles and Criteria for the Level of Patient Cost-Sharing: Reflections on Value-Based Insurance","author":"I Cleemput","year":"2012","unstructured":"Cleemput, I., Devos, C., Devriese, S., Farfan-Portet, M.-I., Van de Voorde, C.: Principles and Criteria for the Level of Patient Cost-Sharing: Reflections on Value-Based Insurance. Health Services Research, Brussels (2012)"},{"key":"1125_CR42","volume-title":"Poor Britain","author":"J Mack","year":"1985","unstructured":"Mack, J., Lansley, S.: Poor Britain. Allen and Unwin, London (1985)"},{"key":"1125_CR43","volume-title":"Measuring Material Deprivation the EU\u2014Indicators for the Whole Population and Child-Specific Indicators","author":"European Commission","year":"2012","unstructured":"Commission, European: Measuring Material Deprivation the EU\u2014Indicators for the Whole Population and Child-Specific Indicators. European Commission, Luxembourg (2012)"},{"issue":"3","key":"1125_CR44","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1017\/S0047279406009834","volume":"35","author":"B Haller\u00f6d","year":"2006","unstructured":"Haller\u00f6d, B.: Sour grapes: relative deprivation, adaptive preferences and the measurement of poverty. J. Soc. Policy. 35(3), 371\u2013390 (2006)","journal-title":"J. Soc. Policy."},{"issue":"4","key":"1125_CR45","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jae.764","volume":"19","author":"R Winkelmann","year":"2004","unstructured":"Winkelmann, R.: Health care reform and the number of doctor visits\u2014an econometric analysis. J. Appl. Econom. 19(4), 455\u2013472 (2004)","journal-title":"J. Appl. Econom."},{"issue":"22","key":"1125_CR46","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1056\/NEJMsa054436","volume":"354","author":"J Hsu","year":"2006","unstructured":"Hsu, J., Price, M., Huang, J., et al.: Unintended consequences of caps on medicare drug benefits. N. Engl. J. Med. 354(22), 2349\u20132359 (2006)","journal-title":"N. Engl. J. Med."},{"key":"1125_CR47","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jhealeco.2015.01.006","volume":"41","author":"P Ayyagari","year":"2015","unstructured":"Ayyagari, P., Shane, D.M.: Does prescription drug coverage improve mental health? Evidence from Medicare Part D. J. Health Econ. 41, 46\u201358 (2015)","journal-title":"J. Health Econ."},{"key":"1125_CR48","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/pds.3917","volume":"25","author":"SJ Sinnott","year":"2016","unstructured":"Sinnott, S.J., Charles, N., Byrne, S., Woods, N., Whelton, H.: Copayments for prescription medicines on a public health insurance scheme in Ireland. Pharmacoepidemiol. Drug Saf. 25, 695\u2013704 (2016)","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"1","key":"1125_CR49","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0165-1765(03)00032-6","volume":"80","author":"C Ai","year":"2003","unstructured":"Ai, C., Norton, E.C.: Interaction terms in logit and probit models. Econ. Lett. 80(1), 123\u2013129 (2003)","journal-title":"Econ. Lett."},{"issue":"1","key":"1125_CR50","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1475-6773.2011.01314.x","volume":"47","author":"P Karaca-Mandic","year":"2012","unstructured":"Karaca-Mandic, P., Norton, E.C., Dowd, B.: Interaction terms in nonlinear models. Health Serv. Res. 47(1), 255\u2013274 (2012)","journal-title":"Health Serv. Res."},{"issue":"1","key":"1125_CR51","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1162\/003355304772839588","volume":"119","author":"M Bertrand","year":"2004","unstructured":"Bertrand, M., Duflo, E., Mullainathan, S.: How much should we trust differences-in-differences estimates? Q. J. Econ. 119(1), 249\u2013275 (2004)","journal-title":"Q. J. Econ."},{"key":"1125_CR52","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1146\/annurev-publhealth-040617-013507","volume":"39","author":"C Wing","year":"2018","unstructured":"Wing, C., Simon, K., Bello-gomez, R.A.: Designing difference in difference studies: best practices for public health policy research. Annu. Rev. Public Health 39, 453\u2013469 (2018)","journal-title":"Annu. Rev. Public Health"},{"key":"1125_CR53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12913-014-0652-8","volume":"15","author":"SY Kwak","year":"2015","unstructured":"Kwak, S.Y., Yoon, S.J., Oh, I.H., Kim, Y.E.: An evaluation on the effect of the copayment waiver policy for Korean hospitalized children under the age of six. BMC Health Serv. Res. 15, 1 (2015)","journal-title":"BMC Health Serv. Res."},{"issue":"1","key":"1125_CR54","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/fampra\/cms049","volume":"30","author":"K Linnet","year":"2013","unstructured":"Linnet, K., Halld\u00f3rsson, M., Thengilsd\u00f3ttir, G., Einarsson, \u00d3.B., J\u00f3nsson, K., Almarsd\u00f3ttir, A.B.: Primary non-adherence to prescribed medication in general practice: lack of influence of moderate increases in patient copayment. Fam. Pract. 30(1), 69\u201375 (2013)","journal-title":"Fam. Pract."},{"issue":"3","key":"1125_CR55","first-page":"259","volume":"49","author":"CT Whelan","year":"2018","unstructured":"Whelan, C.T.: Economic stress and the great recession in Ireland: the erosion of social class advantage. Econ. Soc. Rev. (Irel). 49(3), 259\u2013286 (2018)","journal-title":"Econ. Soc. Rev. (Irel)."},{"key":"1125_CR56","volume-title":"How Medicaid and CHIP Shield Children from the Rising Costs of Prescription Drugs","author":"J Hoadley","year":"2017","unstructured":"Hoadley, J., Alker, J.: How Medicaid and CHIP Shield Children from the Rising Costs of Prescription Drugs. Georgetown University Health Policy Institute, Georgetown (2017)"},{"issue":"2","key":"1125_CR57","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1542\/peds.2008-2869","volume":"124","author":"L Vernacchio","year":"2009","unstructured":"Vernacchio, L., Kelly, J., Kaufman, D., Mitchell, A.: Medication use among children\u2009<\u200912\u00a0years of age in the United States: results from the Slone Survey. Pediatrics 124(2), 446\u2013454 (2009)","journal-title":"Pediatrics"},{"key":"1125_CR58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6963-13-16","volume":"13","author":"SJ Sinnott","year":"2013","unstructured":"Sinnott, S.J., Guinane, M., Whelton, H., Byrne, S.: Is 50 cent the price of the optimal copayment? A qualitative study of patient opinions and attitudes in response to a 50 cent charge on prescription drugs in a publicly funded health system in Ireland. BMC Health Serv. Res. 13, 1 (2013)","journal-title":"BMC Health Serv. Res."},{"issue":"6","key":"1125_CR59","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.sapharm.2015.11.001","volume":"12","author":"P Norris","year":"2016","unstructured":"Norris, P., Ph, D., Tordoff, J., et al.: Impact of prescription charges on people living in poverty: a qualitative study. Res. Soc. Adm. Pharm. 12(6), 893\u2013902 (2016)","journal-title":"Res. Soc. Adm. Pharm."},{"issue":"11","key":"1125_CR60","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1002\/hec.868","volume":"13","author":"R Winkelmann","year":"2004","unstructured":"Winkelmann, R.: Co-payments for prescription drugs and the demand for doctor visits: evidence from a natural experiment. Health Econ. 13(11), 1181\u20131189 (2004)","journal-title":"Health Econ."},{"key":"1125_CR61","first-page":"SP35","volume":"11","author":"MM Murawski","year":"2005","unstructured":"Murawski, M.M., Abdelgawad, T.: Exploration of the impact of preferred drug lists on hospital and physician visits and the costs to Medicaid. Am. J. Manag. Care. 11, SP35\u2013SP42 (2005)","journal-title":"Am. J. Manag. Care."},{"key":"1125_CR62","volume-title":"Budget 2018 Primary Care Reimbursement Service Trend Analysis","author":"Department of Public Expenditure and Reform","year":"2017","unstructured":"Department of Public Expenditure and Reform: Budget 2018 Primary Care Reimbursement Service Trend Analysis. Department of Public Expenditure and Reform, Dublin (2017)"},{"key":"1125_CR63","volume-title":"Primary Care Reimbursement Service Statistical Analysis of Claims and Payments 2017","author":"Health Service Executive","year":"2017","unstructured":"Health Service Executive: Primary Care Reimbursement Service Statistical Analysis of Claims and Payments 2017. Health Service Executive, Dublin (2017)"},{"key":"1125_CR64","first-page":"1","volume":"2017","author":"SG Morgan","year":"2017","unstructured":"Morgan, S.G., Lee, A.: Cost-related non-adherence to prescribed medicines among older adults: a cross-sectional analysis of a survey in 11 developed countries. BMJ Open. 2017, 1\u20137 (2017)","journal-title":"BMJ Open."},{"key":"1125_CR65","doi-asserted-by":"crossref","DOI":"10.1596\/978-92-4-151355-5","volume-title":"Tracking Universal Health Coverage: 2017 Global Monitoring Report","author":"World Health Organization","year":"2017","unstructured":"World Health Organization: Tracking Universal Health Coverage: 2017 Global Monitoring Report. World Health Organization, Geneva (2017)"},{"issue":"9","key":"1125_CR66","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.healthpol.2015.07.008","volume":"119","author":"H Yu","year":"2015","unstructured":"Yu, H.: Universal health insurance coverage for 1.3 billion people: What accounts for China\u2019s success? Health Policy (New York). 119(9), 1145\u20131152 (2015)","journal-title":"Health Policy (New York)."},{"issue":"12","key":"1125_CR67","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.healthpol.2016.05.012","volume":"120","author":"Heever AM Van Den","year":"2016","unstructured":"Van Den, Heever A.M.: South Africa\u2019s universal health coverage reforms in the post-apartheid period. Health Policy (New York). 120(12), 1420\u20131428 (2016)","journal-title":"Health Policy (New York)."},{"issue":"3","key":"1125_CR68","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.healthpol.2016.12.012","volume":"121","author":"R Alshamsan","year":"2017","unstructured":"Alshamsan, R., Leslie, H., Majeed, A., Kruk, M.: Financial hardship on the path to Universal Health Coverage in the Gulf States. Health Policy (New York). 121(3), 315\u2013320 (2017)","journal-title":"Health Policy (New York)."},{"key":"1125_CR69","volume-title":"Sl\u00e1intecare Implementation Strategy","author":"Government of Ireland","year":"2018","unstructured":"Government of Ireland: Sl\u00e1intecare Implementation Strategy. Government of Ireland, Dublin (2018)"}],"container-title":["The European Journal of Health Economics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10198-019-01125-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10198-019-01125-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10198-019-01125-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T04:09:48Z","timestamp":1664856588000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10198-019-01125-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,8]]},"references-count":69,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["1125"],"URL":"https:\/\/doi.org\/10.1007\/s10198-019-01125-3","relation":{},"ISSN":["1618-7598","1618-7601"],"issn-type":[{"value":"1618-7598","type":"print"},{"value":"1618-7601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,8]]},"assertion":[{"value":"1 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}